Colgate-Palmolive (CL) Shares Sold by Honkamp Krueger Financial Services Inc.

Honkamp Krueger Financial Services Inc. cut its stake in Colgate-Palmolive (NYSE:CL) by 6.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 18,013 shares of the company’s stock after selling 1,265 shares during the period. Honkamp Krueger Financial Services Inc.’s holdings in Colgate-Palmolive were worth $1,312,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in CL. OLD Second National Bank of Aurora bought a new stake in shares of Colgate-Palmolive during the second quarter worth approximately $109,000. Krilogy Financial LLC raised its stake in shares of Colgate-Palmolive by 23.0% during the second quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after buying an additional 289 shares during the last quarter. Harbour Capital Advisors LLC bought a new stake in shares of Colgate-Palmolive during the first quarter worth approximately $121,000. Hanson & Doremus Investment Management raised its stake in shares of Colgate-Palmolive by 4.5% during the second quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock worth $121,000 after buying an additional 70 shares during the last quarter. Finally, Captrust Financial Advisors bought a new stake in shares of Colgate-Palmolive during the second quarter worth approximately $122,000. 72.96% of the stock is owned by institutional investors.

A number of research firms recently weighed in on CL. Deutsche Bank began coverage on shares of Colgate-Palmolive in a research note on Wednesday. They set a “hold” rating and a $75.00 price target for the company. Societe Generale downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 price target for the company. in a research note on Wednesday, November 29th. They noted that the move was a valuation call. KeyCorp reissued a “hold” rating on shares of Colgate-Palmolive in a research note on Saturday, November 25th. Zacks Investment Research raised shares of Colgate-Palmolive from a “sell” rating to a “hold” rating in a research note on Wednesday, November 8th. Finally, Citigroup decreased their price objective on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a report on Thursday, November 2nd. Two investment analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and four have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $76.04.

In other news, insider Jennifer Daniels sold 7,375 shares of the company’s stock in a transaction that occurred on Wednesday, December 13th. The shares were sold at an average price of $73.18, for a total value of $539,702.50. Following the completion of the transaction, the insider now owns 38,691 shares in the company, valued at $2,831,407.38. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CMO Mukul Deoras sold 7,500 shares of the company’s stock in a transaction that occurred on Friday, November 10th. The shares were sold at an average price of $73.28, for a total transaction of $549,600.00. Following the completion of the transaction, the chief marketing officer now owns 45,217 shares of the company’s stock, valued at approximately $3,313,501.76. The disclosure for this sale can be found here. Insiders sold 181,048 shares of company stock valued at $13,168,995 in the last quarter. Corporate insiders own 1.02% of the company’s stock.

Colgate-Palmolive (CL) opened at $74.05 on Friday. The stock has a market cap of $65,023.68, a P/E ratio of 25.80, a P/E/G ratio of 3.39 and a beta of 0.81. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23. Colgate-Palmolive has a 1-year low of $63.43 and a 1-year high of $77.27.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.73. The firm had revenue of $3.97 billion during the quarter, compared to analysts’ expectations of $3.94 billion. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The business’s revenue for the quarter was up 2.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.73 earnings per share. equities analysts forecast that Colgate-Palmolive will post 2.88 EPS for the current year.

WARNING: “Colgate-Palmolive (CL) Shares Sold by Honkamp Krueger Financial Services Inc.” was originally published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this article on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The original version of this article can be read at https://sportsperspectives.com/2017/12/17/colgate-palmolive-cl-shares-sold-by-honkamp-krueger-financial-services-inc.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply